These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 37621240)

  • 41. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study.
    Cuellar-Gómez H; Ocharán-Hernández ME; Calzada-Mendoza CC; Comoto-Santacruz DA
    Rev Gastroenterol Mex (Engl Ed); 2022; 87(3):277-284. PubMed ID: 34312118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gut Microbial Signatures in Sporadic and Hereditary Colorectal Cancer.
    Mori G; Pasca MR
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525662
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dietary modulation of gut microbiota in patients with colorectal cancer undergoing surgery: A review.
    Martínez-Montoro JI; Martínez-Sánchez MA; Balaguer-Román A; Gil-Martínez J; Mesa-López MJ; Egea-Valenzuela J; Ruiz-Alcaraz AJ; Queipo-Ortuño MI; Ferrer M; Fernández-García JC; Ramos-Molina B
    Int J Surg; 2022 Aug; 104():106751. PubMed ID: 35803517
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploring the Relationship Between Diet, Lifestyle and Gut Microbiome in Colorectal Cancer Development: A Recent Update.
    Saha B; A T R; Adhikary S; Banerjee A; Radhakrishnan AK; Duttaroy AK; Pathak S
    Nutr Cancer; 2024; 76(9):789-814. PubMed ID: 39207359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gut microbiome as a treatment in colorectal cancer.
    Khan M; Shah S; Shah W; Khan I; Ali H; Ali I; Ullah R; Wang X; Mehmood A; Wang Y
    Int Rev Immunol; 2024; 43(4):229-247. PubMed ID: 38343353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting the gut microbiota: a new strategy for colorectal cancer treatment.
    Hu Y; Zhou P; Deng K; Zhou Y; Hu K
    J Transl Med; 2024 Oct; 22(1):915. PubMed ID: 39379983
    [TBL] [Abstract][Full Text] [Related]  

  • 47.
    Hong J; Guo F; Lu SY; Shen C; Ma D; Zhang X; Xie Y; Yan T; Yu T; Sun T; Qian Y; Zhong M; Chen J; Peng Y; Wang C; Zhou X; Liu J; Liu Q; Ma X; Chen YX; Chen H; Fang JY
    Gut; 2021 Nov; 70(11):2123-2137. PubMed ID: 33318144
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of gut microbiota in epigenetic regulation of colorectal Cancer.
    Zhao Y; Wang C; Goel A
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188490. PubMed ID: 33321173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disease-associated gut microbiome and critical metabolomic alterations in patients with colorectal cancer.
    Zhang H; Jin K; Xiong K; Jing W; Pang Z; Feng M; Cheng X
    Cancer Med; 2023 Jul; 12(14):15720-15735. PubMed ID: 37260140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of Microbiome in Carcinogenesis Process and Epigenetic Regulation of Colorectal Cancer.
    Farhana L; Banerjee HN; Verma M; Majumdar APN
    Methods Mol Biol; 2018; 1856():35-55. PubMed ID: 30178245
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progress of gut microbiome and its metabolomics in early screening of colorectal cancer.
    Zhou L; Jiang Z; Zhang Z; Xing J; Wang D; Tang D
    Clin Transl Oncol; 2023 Jul; 25(7):1949-1962. PubMed ID: 36790675
    [TBL] [Abstract][Full Text] [Related]  

  • 52. YYFZBJS ameliorates colorectal cancer progression in Apc
    Sui H; Zhang L; Gu K; Chai N; Ji Q; Zhou L; Wang Y; Ren J; Yang L; Zhang B; Hu J; Li Q
    Cell Commun Signal; 2020 Jul; 18(1):113. PubMed ID: 32677955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential Role of the Gut Microbiome In Colorectal Cancer Progression.
    Kim J; Lee HK
    Front Immunol; 2021; 12():807648. PubMed ID: 35069592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The Power of the Gut Microbiome: Exploring New Perspectives in Colorectal Cancer Therapy].
    Takeda M; Doki Y
    Gan To Kagaku Ryoho; 2024 Jun; 51(6):608-612. PubMed ID: 39009515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of Probiotics in Modulating Human Gut Microbiota Populations and Activities in Patients with Colorectal Cancer-A Systematic Review of Clinical Trials.
    Wierzbicka A; Mańkowska-Wierzbicka D; Mardas M; Stelmach-Mardas M
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33915854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
    Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
    Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic potential of melatonin in colorectal cancer: Focus on lipid metabolism and gut microbiota.
    Pan S; Guo Y; Hong F; Xu P; Zhai Y
    Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166281. PubMed ID: 34610472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of gut microbiota in the development of colorectal cancer: a review.
    Koyande N; Gangopadhyay M; Thatikonda S; Rengan AK
    Int J Colorectal Dis; 2022 Jul; 37(7):1509-1523. PubMed ID: 35704091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Remodeling of the Gut Microbiota in Colorectal Cancer and its Association with Obesity.
    Zafari N; Velayati M; Mehrabadi S; Damavandi S; Khazaei M; Hassanian SM; Ferns GA; Avan A
    Curr Pharm Des; 2023; 29(4):256-271. PubMed ID: 36654469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
    Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
    World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.